Pacira Pharmaceuticals reported $154.98M in Operating Expenses for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Aerie Pharmaceuticals AERI:US $ 62.93M 1.24M
Depomed DEPO:US $ 19.54M 17.84M
Ironwood Pharmaceuticals IRWD:US $ 39.68M 20.86M
Nektar Therapeutics NKTR:US $ 137.92M 598K
Teva Pharmaceutical TEVA:IT 4.02B 758M
Xoma XOMA:US $ 5.17M 408K
Zoetis ZTS:US $ 1.46B 130M